BusinessMoneycontrol
Star Health Q1 profit beats estimates; Nomura raises target price to Rs 700, maintains Buy
in5points
Star Health's Q1 profit exceeded estimates.
Nomura raised its target price for Star Health to Rs 700 from an earlier level.
Nomura maintained a 'Buy' rating on Star Health.
Nomura increased its net profit estimates for Star Health by 1-11% over FY27-FY29.
The estimate revision was driven by stronger-than-expected core performance and investment income.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Moneycontrol
Center-right
Mixed factuality
